Can Osteopenia Induce Residual Dizziness After Treatment of Benign Paroxysmal Positional Vertigo?

Objective: This study aimed to determine whether there is an association between osteopenia and residual dizziness after successful treatment of benign paroxysmal positional vertigo (BPPV). Methods: In all, 62 patients with canalolithiasis-type BPPV were included in the study. Patients were divided into two groups according to the presence of residual dizziness after resolution of BPPV. Univariate and multivariate analyses were performed to determine the factors associated with residual dizziness. Patients were analyzed based on age, sex, affected semicircular canal, affected side, BPPV duration, and presence of hypertension, diabetes mellitus, hyperlipidemia, and osteopenia. Results: In univariate analysis, BPPV duration and osteopenia showed a relatively significant association ( p < 0.20) with the development of residual dizziness. On subsequent multivariate analysis using these factors, osteopenia remained a statistically significant factor in association with residual dizziness ( p = 0.012, odds ratio, 9.916). Conclusion: Osteopenia is associated with the development of residual dizziness. BPPV patients with osteopenia more frequently suffer from residual dizziness after successful treatment of BPPV than those without osteopenia.